Short answer: Clomid (clomiphene) is FDA approved to treat ovulation problems in women trying to get pregnant. Letrozole (Femara) is approved only for breast cancer after menopause, so using it to bring on ovulation is off label.12 In one trial of 750 women with polycystic ovary syndrome, letrozole led to more live births than clomiphene: 27.5% vs 19.1%.3
| Letrozole (Femara) | Clomiphene (Clomid) | |
|---|---|---|
| How it works | Aromatase inhibitor: lowers estrogen production2 | Competes with estrogen at estrogen receptors, including in the hypothalamus and pituitary1 |
| FDA-approved use | Breast cancer in postmenopausal women only. Not approved for ovulation induction2 | Ovulation problems in women who want to become pregnant1 |
| Label dose | 2.5 mg once daily, for breast cancer. No fertility dosing on the label2 | 50 mg daily for 5 days, started around day 5 of the cycle; if no ovulation, 100 mg daily for 5 days. No higher1 |
| Course limits | None for fertility (not a labeled use)2 | Stop after 3 courses without ovulation, or 3 ovulatory cycles without pregnancy; about 6 cycles in total1 |
| Half-life | About 2 days2 | No single figure; the zuclomiphene part stayed detectable for more than a month1 |
| Pregnancy | Contraindicated in pregnancy; can cause fetal harm. Pregnancy test before starting2 | Contraindicated in pregnancy; check for pregnancy before each new cycle1 |
| PCOS trial: live births | 27.5%3 | 19.1%3 |
| PCOS trial: ovulation (per cycle) | 61.7%3 | 48.3%3 |
| PCOS trial: twins | 3.4%3 | 7.4% (difference not significant)3 |
| Common side effects | In the PCOS trial: more fatigue and dizziness3 | Label: ovarian enlargement 13.6%, hot flushes 10.4%, visual symptoms 1.5%. In the PCOS trial: more hot flushes13 |
No. The Femara label lists three uses, all breast cancer treatment in postmenopausal women, at 2.5 mg once a day.2 It also says letrozole is contraindicated in pregnancy and asks for a pregnancy test before starting.2 Fertility clinics prescribe it off label, so the timing and dose come from your clinic, not from the label.
Clomid's label is written for ovulation induction: 50 mg a day for 5 days, then 100 mg a day for 5 days only if ovulation does not happen, with ovulation usually 5 to 10 days after a course.1
Legro and colleagues randomly assigned 750 women aged 18 to 40 with polycystic ovary syndrome to letrozole or clomiphene for up to five cycles, in a double-blind trial.3
The trial was only in women with polycystic ovary syndrome, so it does not tell us how the two compare for other causes of infertility.
More detail: Clomid side effects, Femara side effects, the Clomid and Femara dosing schedules, a missed Femara dose, and how to store Femara and Clomid.